83 related articles for article (PubMed ID: 28365965)
1. Polymorphisms of survivin -31 G/C gene are associated with risk of urothelial carcinoma in Serbian population.
Bogdanovic L; Lazic M; Bogdanovic J; Soldatovic I; Nikolic N; Radunovic M; Radojevic-Skodric S; Milasin J; Basta-Jovanovic G
J BUON; 2017; 22(1):270-277. PubMed ID: 28365965
[TBL] [Abstract][Full Text] [Related]
2. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
[TBL] [Abstract][Full Text] [Related]
3. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
[TBL] [Abstract][Full Text] [Related]
4. Survivin gene promoter -31 G/C polymorphism is associated with Wilms tumor susceptibility in Serbian children.
Radojevic-Skodric S; Basta-Jovanovic G; Brasanac D; Nikolic N; Bogdanovic L; Milicic B; Milasin J
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e310-4. PubMed ID: 22858571
[TBL] [Abstract][Full Text] [Related]
5. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
[TBL] [Abstract][Full Text] [Related]
6. Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
Rapti E; Gazouli M; Legaki E; Karamanolis G; Thomas D; Marinos E; Papaconstantinou I
Genet Test Mol Biomarkers; 2015 Jun; 19(6):339-43. PubMed ID: 25918954
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of TNF-
Wu CC; Huang YK; Huang CY; Shiue HS; Pu YS; Su CT; Lin YC; Hsueh YM
Biomed Res Int; 2018; 2018():3148137. PubMed ID: 29951534
[TBL] [Abstract][Full Text] [Related]
8. Epistatic interaction between adiponectin and survivin gene polymorphisms in endometrial carcinoma.
Aminimoghaddam S; Shahrabi-Farahani M; Mohajeri-Tehrani M; Amiri P; Fereidooni F; Larijani B; Shafiee G; Amoli MM
Pathol Res Pract; 2015 Apr; 211(4):293-7. PubMed ID: 25613698
[TBL] [Abstract][Full Text] [Related]
9. XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma.
Chiang CI; Huang YL; Huang CY; Shiue HS; Chen WJ; Pu YS; Lin YC; Hsueh YM
PLoS One; 2015; 10(5):e0124066. PubMed ID: 25938407
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
[TBL] [Abstract][Full Text] [Related]
11. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
[TBL] [Abstract][Full Text] [Related]
12. Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer.
Chang WS; Lin SS; Li FJ; Tsai CW; Li LY; Lien CS; Liao WL; Wu HC; Tsai CH; Shih TC; Bau DT
Anticancer Res; 2013 Nov; 33(11):4907-12. PubMed ID: 24222128
[TBL] [Abstract][Full Text] [Related]
13. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.
Chung CJ; Pu YS; Shiue HS; Lee HL; Lin P; Yang HY; Su CT; Hsueh YM
Toxicol Lett; 2013 Jan; 216(1):16-22. PubMed ID: 23142425
[TBL] [Abstract][Full Text] [Related]
14. Investigation of
Kafadar D; Yaylim I; Kafadar AM; Cacina C; Ergen A; Kaynar MY; Isbir T
Anticancer Res; 2018 Oct; 38(10):5991-5998. PubMed ID: 30275230
[TBL] [Abstract][Full Text] [Related]
15. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
16. Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population.
Lin YC; Hour TC; Tsai YC; Huang SP; Wu WJ; Chen CH; Pu YS; Chung SD; Huang CY
Urol Oncol; 2017 Sep; 35(9):543.e7-543.e16. PubMed ID: 28668478
[TBL] [Abstract][Full Text] [Related]
17. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
[TBL] [Abstract][Full Text] [Related]
18. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
Cheng ZJ; Hu LH; Huang SJ
Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
[TBL] [Abstract][Full Text] [Related]
20. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
